Zhejiang Hengtong Holding Co., Ltd. (600226.SS), formerly known as Zhejiang Hugeleaf Co., Ltd., is a China-based multiline utilities company primarily engaged in the chemical and thermal power businesses; the chemical segment produces veterinary drugs, feed additives, and pesticides including L-tryptophan premix, L-tryptophan boutique, and abamectin, while the thermal power segment provides combined heat and power generation along with central heating, supplying electricity and steam; operations also encompass research, development, production, and sales of electrolytic copper foil and chemical raw materials, serving domestic and overseas markets with a focus on industrial manufacturing. Headquartered in Huzhou, Zhejiang Province, the company, founded prior to its 1999 listing on the Shanghai Stock Exchange, maintains approximately 817 employees and generates the majority of its sales from China. In July 2024, Zhejiang Hengtong Holding signed a letter of intent to acquire the remaining 49% stake in Hengtong Precision Copper Foil Technology (Deyang) Co., Ltd. from Jiangsu Hengtong Precision Copper Co., Ltd. for approximately CNY 293 million in cash, achieving 100% ownership of the subsidiary upon completion, which was approved by shareholders in August 2024; this transaction bolsters its position in high-precision copper foil production amid growing demand in new energy applications.